📍 WASHINGTON D.C., USA
02.11.2026
FDA Initiates Rare Legal Proceedings to Revoke Approval of Kidney Drug Tavneos
The United States Food and Drug Administration has initiated complex regulatory proceedings aimed at withdrawing its market approval for Tavneos, an autoimmune therapeutic used to treat severe vasculitis, citing evidence...